[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Berggren et al., 2011 - Google Patents

Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections

Berggren et al., 2011

Document ID
14374117613544379483
Author
Berggren A
Lazou Ahrén I
Larsson N
Önning G
Publication year
Publication venue
European journal of nutrition

External Links

Snippet

Background The aim of this study was to investigate whether consumption of Lactobacillus plantarum HEAL 9 (DSM 15312) and Lactobacillus paracasei 8700: 2 (DSM 13434) could affect naturally acquired common cold infections in healthy subjects. Methods A randomised …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Berggren et al. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections
Bustamante et al. Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract
Roessler et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention
Lenoir-Wijnkoop et al. Probiotic and prebiotic influence beyond the intestinal tract
Sur et al. Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum
Urbańska et al. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
Vyas et al. Probiotics, prebiotics, and synbiotics: gut and beyond
JP2022078050A (en) Gold kiwifruit compositions and methods of preparation and use therefor
Minocha Probiotics for preventive health
Matsumoto et al. LKM512 yogurt consumption improves the intestinal environment and induces the T‐helper type 1 cytokine in adult patients with intractable atopic dermatitis
Passariello et al. Randomised clinical trial: efficacy of a new synbiotic formulation containing L actobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea
Ogden et al. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease
Uchida et al. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome
Pandey et al. Probiotics: Healthy bugs and nourishing elements of diet
Bi et al. Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo-controlled trial
CA2702293C (en) Probiotics for use in relieving symptoms associated with gastrointestinal disorders
MacDonald et al. Specific prebiotics in a formula for infants with Phenylketonuria
Parkes An overview of probiotics and prebiotics
Banerjee et al. Importance of probiotics in human health
Perna et al. Is Probiotic Supplementation Useful for the Management of Body Weight and Other Anthropometric Measures in Adults Affected by Overweight and Obesity with Metabolic Related Diseases? A Systematic Review and Meta-Analysis. Nutrients [online] 2021 Feb 19 [cited 2021 July 11]; 13 (2): 1-18
JP7260903B2 (en) Food composition for reducing stress containing lactose fructose oligosaccharide (lactosucrose) as an active ingredient
Meirlaen et al. Probiotics in the prevention and management of allergic diseases (asthma and allergic rhinitis)
US20240226196A9 (en) Composition and Use Thereof
US9937213B2 (en) Composition comprising L. rhamnosus GG
US20190091270A1 (en) Probiotics for use in relieving symptoms associated with gastrointestinal disorders